Emerging evidence suggests that pitavastatin triggers mitophagy though the calcium-dependent CAMK1-PINK1 pathway to promote endothelial progenitor cell (EPC) proliferation and retard the progression of atherosclerosis, hinting that statins may hold the potential therapeutic effect on the treatment of CRS4 (Yang et al., 2022). Here, PINK1 is linked to atherosclerosis.